In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies).

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis

Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa.

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.

Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient

[Use of dried blood from the heel (Guthrie card) in the diagnosis of congenital enterovirus infection].

Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients.

Procedimientos en Microbiología Clínica (número 71, 2.a edición 2021)

Norovirus outbreak causing gastroenteritis in a hotel in Menorca, Spain.

First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus.

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old.

[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2].

[Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2].

Detection of respiratory viruses in patients with suspected SARS-CoV-2 infection.

Influenza vaccination in the time of SARS-CoV-2.

[Impact of spike genetic variants in vaccines against SARS-CoV-2].

[Impact of hygienic and social distancing measures against SARS-CoV-2 on respiratory infections caused by other viruses].

La nueva generación de vacunas de ARN mensajero (ARNm) frente a la gripe

Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2.